BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37643427)

  • 1. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
    Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
    Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the
    Hopfensperger KM; Adams Q; Kim Y; Wu X; Xu W; Patwardhan K; Thammavong B; Caster J; Flynn RT
    Med Phys; 2020 Jun; 47(5):2061-2071. PubMed ID: 32073669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multihelix rotating shield brachytherapy for cervical cancer.
    Dadkhah H; Kim Y; Wu X; Flynn RT
    Med Phys; 2015 Nov; 42(11):6579-88. PubMed ID: 26520749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Yang W; Wu X
    Med Phys; 2013 Dec; 40(12):121703. PubMed ID: 24320489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel minimally invasive dynamic-shield, intensity-modulated brachytherapy system for the treatment of cervical cancer.
    Morcos M; Antaki M; Viswanathan AN; Enger SA
    Med Phys; 2021 Jan; 48(1):71-79. PubMed ID: 32916763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paddle-based rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Dadkhah H; Bhatia SK; Buatti JM; Xu W; Wu X
    Med Phys; 2015 Oct; 42(10):5992-6003. PubMed ID: 26429274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy.
    Liu Y; Flynn RT; Kim Y; Wu X
    Med Phys; 2014 Nov; 41(11):111709. PubMed ID: 25370623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast dose optimization for rotating shield brachytherapy.
    Cho M; Wu X; Dadkhah H; Yi J; Flynn RT; Kim Y; Xu W
    Med Phys; 2017 Oct; 44(10):5384-5392. PubMed ID: 28744870
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Adams Q; Hopfensperger KM; Kim Y; Wu X; Flynn RT
    Med Phys; 2020 Dec; 47(12):6430-6439. PubMed ID: 33051866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid emission angle selection for rotating-shield brachytherapy.
    Liu Y; Flynn RT; Yang W; Kim Y; Bhatia SK; Sun W; Wu X
    Med Phys; 2013 May; 40(5):051720. PubMed ID: 23635268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotating-shield brachytherapy for cervical cancer.
    Yang W; Kim Y; Wu X; Song Q; Liu Y; Bhatia SK; Sun W; Flynn RT
    Phys Med Biol; 2013 Jun; 58(11):3931-41. PubMed ID: 23680601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of rotatable tandem applicator to conventional ovoid applicator toward complete framework of intensity modulated brachytherapy (IMBT) for cervical cancer.
    Kim H; Goh Y; Kim DW; Kim JS; Lim YK
    Phys Med; 2021 Nov; 91():131-139. PubMed ID: 34800907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the impact of absorbed dose specification, tissue heterogeneities, and applicator heterogeneities on Monte Carlo-based dosimetry of Ir-192, Se-75, and Yb-169 in conventional and intensity-modulated brachytherapy for the treatment of cervical cancer.
    Morcos M; Viswanathan AN; Enger SA
    Med Phys; 2021 May; 48(5):2604-2613. PubMed ID: 33619739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel
    Famulari G; Duclos M; Enger SA
    Med Phys; 2020 Mar; 47(3):859-868. PubMed ID: 31828783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
    Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
    Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial rotating shield brachytherapy for prostate cancer.
    Adams QE; Xu J; Breitbach EK; Li X; Enger SA; Rockey WR; Kim Y; Wu X; Flynn RT
    Med Phys; 2014 May; 41(5):051703. PubMed ID: 24784369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical design.
    Han DY; Webster MJ; Scanderbeg DJ; Yashar C; Choi D; Song B; Devic S; Ravi A; Song WY
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):666-73. PubMed ID: 24751413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Dosimetric Influence of Applicator Displacement on 2D and 3D Brachytherapy for Cervical Cancer Treatment.
    Wu A; Tang D; Wu A; Liu Y; Qian L; Zhu L
    Technol Cancer Res Treat; 2021; 20():15330338211041201. PubMed ID: 34569371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.